BioIntelliSense's BioSticker Receives FDA's 510 (k) Clearance for Month-Long Vitals Monitoring
Shots:
- BioIntelliSense launches its medical-grade Data-as-a-Service (DaaS) platform and has received 510(k) clearance for BioSticker on-body sensor for scalable remote care in the US
- The company has developed BioSticker device in collaboration with UC Health and its CARE Innovation Center to monitor the patient’s health in their home- thus reducing hospitalizations- emergency department visits and shorten hospital stays leading towards a cost-effective health
- The BioSticker can monitor all vital activities for up to a continuous thirty days- providing physicians with an impressive set of data that can keep clues to patients’ diseases and conditions. The device is single-use and is disposed of after a patient is done wearing it
Click here to read full press release/ article | Ref: BioIntelliSense | Image: Wearable Technology
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
